- Active not recruitingPHASE2
A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
This study looked at a new medicine called ARGX-119 for adults with Amyotrophic Lateral Sclerosis (ALS) to see if it was safe and helped with muscle function. The study stopped early, not because of safety worries, but because it was unlikely to show a clear benefit.
For: Amyotrophic Lateral SclerosisBelgium · Canada · Denmark - RecruitingPHASE1
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
This study is testing a new medicine, ARGX-119, for adults with a specific type of muscle weakness called DOK7-Congenital Myasthenic Syndrome (CMS). It's looking at how safe the medicine is, if it causes side effects, and if it helps people feel better.
For: Congenital Myasthenic Syndrome · CMSUnited States · Canada · France